Ray Dalio Bio N Tech Se Transaction History
Bridgewater Associates, LP
- $21.1 Billion
- Q4 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Bio N Tech Se stock. As of the latest transaction made, Bridgewater Associates, LP holds 20,277 shares of BNTX stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,277
Previous 5,673
257.43%
Holding current value
$2.02 Million
Previous $673,000
243.24%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$818 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$438 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$427 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$189 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$180 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...